Plain-English translation of NCT06947993 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This research study is testing a new medication called to see if it can help people with moderate to severe atopic dermatitis (a chronic skin condition that causes itching, redness, and inflammation). The study will compare different doses of the medication against a placebo (a dummy pill with no active ingredient) to find out which dose works best and is safest.
Atopic dermatitis can be very uncomfortable and hard to manage with current treatments. Researchers are testing this medication to see if it offers a new, more effective option for people whose skin condition is moderate to severe.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new medication at one of several doses or a placebo. The study has two treatment periods, and depending on which group you are in, you may continue with the same dose or switch doses in the second period. Participants in the placebo group will receive the medication in the second period. You will visit the study center multiple times for check-ins, skin assessments, and blood work to monitor how well the treatment is working and whether you are experiencing any side effects.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States